Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Age-specific severity of SARS-CoV-2 in February 2020 – June 2021 in the Netherlands

Pieter T. de Boer, Jan van de Kassteele, Eric R.A. Vos, Liselotte van Asten, Dave A. Dongelmans, Arianne B. van Gageldonk-Lafeber, View ORCID ProfileGerco den Hartog, Agnetha Hofhuis, Fiona van der Klis, Dylan W. de Lange, Lenny Stoeldraijer, the RIVM COVID-19 epidemiology and surveillance team, Hester E. de Melker, Eveline Geubbels, Susan van den Hof, Jacco Wallinga
doi: https://doi.org/10.1101/2023.02.09.23285703
Pieter T. de Boer
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pieter.de.boer{at}rivm.nl
Jan van de Kassteele
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric R.A. Vos
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liselotte van Asten
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave A. Dongelmans
2Department of Intensive Care Medicine, Amsterdam UMC (location AMC), Amsterdam, the Netherlands
3Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arianne B. van Gageldonk-Lafeber
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerco den Hartog
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
4Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerco den Hartog
Agnetha Hofhuis
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona van der Klis
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dylan W. de Lange
5Intensive Care, University Medical Center Utrecht, University Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lenny Stoeldraijer
6Statistics Netherlands, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
Hester E. de Melker
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eveline Geubbels
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan van den Hof
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacco Wallinga
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
7Department of Biomedical Datasciences, Leiden University Medical Center, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2023.02.09.23285703
History 
  • February 10, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Pieter T. de Boer1,†,
  2. Jan van de Kassteele1,*,
  3. Eric R.A. Vos1,*,
  4. Liselotte van Asten1,
  5. Dave A. Dongelmans2,3,
  6. Arianne B. van Gageldonk-Lafeber1,
  7. Gerco den Hartog1,4,
  8. Agnetha Hofhuis1,
  9. Fiona van der Klis1,
  10. Dylan W. de Lange5,
  11. Lenny Stoeldraijer6,
  12. the RIVM COVID-19 epidemiology and surveillance team1,
  13. Hester E. de Melker1,
  14. Eveline Geubbels1,
  15. Susan van den Hof1,* and
  16. Jacco Wallinga1,7,*
  1. 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
  2. 2Department of Intensive Care Medicine, Amsterdam UMC (location AMC), Amsterdam, the Netherlands
  3. 3Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
  4. 4Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands
  5. 5Intensive Care, University Medical Center Utrecht, University Utrecht, the Netherlands
  6. 6Statistics Netherlands, the Netherlands
  7. 7Department of Biomedical Datasciences, Leiden University Medical Center, the Netherlands
  1. ↵†Correspondence:
    Pieter de Boer (pieter.de.boer{at}rivm.nl)
  1. ↵* These authors contributed equally to the manuscript

Back to top
PreviousNext
Posted February 10, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Age-specific severity of SARS-CoV-2 in February 2020 – June 2021 in the Netherlands
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Age-specific severity of SARS-CoV-2 in February 2020 – June 2021 in the Netherlands
Pieter T. de Boer, Jan van de Kassteele, Eric R.A. Vos, Liselotte van Asten, Dave A. Dongelmans, Arianne B. van Gageldonk-Lafeber, Gerco den Hartog, Agnetha Hofhuis, Fiona van der Klis, Dylan W. de Lange, Lenny Stoeldraijer, the RIVM COVID-19 epidemiology and surveillance team, Hester E. de Melker, Eveline Geubbels, Susan van den Hof, Jacco Wallinga
medRxiv 2023.02.09.23285703; doi: https://doi.org/10.1101/2023.02.09.23285703
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Age-specific severity of SARS-CoV-2 in February 2020 – June 2021 in the Netherlands
Pieter T. de Boer, Jan van de Kassteele, Eric R.A. Vos, Liselotte van Asten, Dave A. Dongelmans, Arianne B. van Gageldonk-Lafeber, Gerco den Hartog, Agnetha Hofhuis, Fiona van der Klis, Dylan W. de Lange, Lenny Stoeldraijer, the RIVM COVID-19 epidemiology and surveillance team, Hester E. de Melker, Eveline Geubbels, Susan van den Hof, Jacco Wallinga
medRxiv 2023.02.09.23285703; doi: https://doi.org/10.1101/2023.02.09.23285703

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)